Endologix, Inc. to Present at the Oppenheimer 27th Annual Healthcare Conference
March 13 2017 - 4:01PM
Business Wire
Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of
innovative treatments for aortic disorders, today announced that
John McDermott, Chairman and Chief Executive Officer, will present
at the Oppenheimer 27th Annual Healthcare Conference at 8:35 a.m.
ET on Wednesday, March 22, 2017 in New York, New York.
A live webcast of the presentation will be accessible through
the “Investors” section of the Company’s website at
www.endologix.com and will be available for replay following the
event.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's focus is
endovascular stent grafts for the treatment of abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the
aorta, the largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and,
if left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is
approximately 80%, making it a leading cause of death in the
United States. For more information,
visit www.endologix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170313006336/en/
Investor:Endologix, Inc.Vaseem Mahboob, CFO(949) 595-7200
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Apr 2023 to Apr 2024